Crypto Millionaire: “Pay Attention to May 20th”

From Investor Place Media | Ad

Charlie Shrem is like the “Godfather of Cryptocurrencies”. He discovered Bitcoin when it was trading for $5. Ethereum at $109. Binance at just $6. Cardano for 5 CENTS.

Today, he’s sharing the details of a $0.21 CENT crypto with Top 5 Potential… as well as his BIG prediction for May 20th.

Get the details NOW.

ORIC Insider Trading (ORIC Pharmaceuticals)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 24.64%

Insider Buying (Last 12 Months): $2,926,880.10

Insider Selling (Last 12 Months): $527,341.83

ORIC Pharmaceuticals Insider Trading History Chart

ORIC Pharmaceuticals Share Price & Price History

^$3.53

▲ +0.72 (25.62%)

As of 05/16/2022 02:46 PM ET

Days: 30 | 90 | 365

How You Should Be Choosing Your Stocks

From Vantage Point | Ad

Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.

We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.

Click here now to join and get access to our forecasting.

ORIC Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/13/2022	Jacob Chacko	CEO	Buy	76,072	$2.82	$214,523.04	802,652
5/11/2022	Jacob Chacko	CEO	Buy	304,574	$2.90	$883,264.60	657,226
3/31/2022	Dominic Piscitelli	CFO	Buy	60,000	$5.36	$321,600.00
3/25/2022	Jacob Chacko	CEO	Buy	50,000	$4.54	$227,000.00
3/23/2022	Jacob Chacko	CEO	Buy	257,127	$4.98	$1,280,492.46
9/15/2021	Jacob Chacko	CEO	Sell	3,736	$25.06	$93,624.16	6,388
9/14/2021	Richard A. Heyman	Director	Sell	706	$25.05	$17,685.30	12,500
9/13/2021	Jacob Chacko	CEO	Sell	2,801	$25.02	$70,081.02	6,388
9/10/2021	Jacob Chacko	CEO	Sell	2,942	$25.08	$73,785.36
9/7/2021	Jacob Chacko	CEO	Sell	5,981	$25.11	$150,182.91	16,751
9/7/2021	Richard A Heyman	Director	Sell	1,086	$25.11	$27,269.46	12,500
5/24/2021	Jacob Chacko	CEO	Sell	12	$25.00	$300.00	27,934
5/24/2021	Richard A Heyman	Director	Sell	100	$25.00	$2,500.00	12,500
5/20/2021	Jacob Chacko	CEO	Sell	2,468	$25.07	$61,872.76	27,934
5/20/2021	Richard A Heyman	Director	Sell	700	$25.08	$17,556.00	12,500
5/17/2021	Richard A Heyman	Director	Sell	498	$25.07	$12,484.86	12,500
5/13/2021	Jacob Chacko	CEO	Sell	730	$25.04	$18,279.20	59,310
5/13/2021	Richard H. Scheller	Director	Sell	100	$25.00	$2,500.00	49,200
5/11/2021	Jacob Chacko	CEO	Sell	1,090	$25.22	$27,489.80	59,310
5/11/2021	Richard A Heyman	Director	Sell	100	$25.11	$2,511.00	49,200
4/30/2021	Jacob Chacko	CEO	Sell	1,300	$25.14	$32,682.00	61,000
4/30/2021	Richard A Heyman	Director	Sell	100	$25.26	$2,526.00	12,500
4/28/2021	Jacob Chacko	CEO	Sell	700	$25.06	$17,542.00	61,000
4/28/2021	Richard A Heyman	Director	Sell	100	$25.08	$2,508.00	12,500
4/1/2021	Jacob Chacko	CEO	Sell	800	$25.09	$20,072.00	61,700
4/1/2021	Richard H. Scheller	Director	Sell	200	$25.00	$5,000.00	49,800
3/29/2021	Carl L. Gordon	Director	Sell	75,555	$23.31	$1,761,187.05
3/26/2021	Orbimed Advisors Llc	Director	Sell	27,816	$23.88	$664,246.08
3/24/2021	Orbimed Advisors Llc	Director	Sell	32,959	$24.80	$817,383.20
3/22/2021	Carl L. Gordon	Director	Sell	7,673	$26.47	$203,104.31
3/19/2021	Carl L. Gordon	Director	Sell	21,275	$26.47	$563,149.25
3/17/2021	Orbimed Advisors Llc	Director	Sell	18,790	$28.43	$534,199.70
3/15/2021	Orbimed Advisors Llc	Director	Sell	89,210	$29.14	$2,599,579.40
3/11/2021	Orbimed Advisors Llc	Director	Sell	58,551	$33.04	$1,934,525.04
4/24/2020	Orbimed Advisors Llc	Director	Buy	281,250	$25.68	$7,222,500.00

This Stock Under $2 Could Go to $20 (And STILL Be a SCREAMING BUY)

From Oxford Club | Ad

Analysts predict earnings will soar more than 320% this year...Possibly as much as 500%!

Discover the last opportunity that could still rocket skyward in THIS market.

Click Here to Discover Details on the Shocking Less Than $2 Stock.

>>>

SEC Filings (Institutional Ownership Changes) for ORIC Pharmaceuticals (NASDAQ:ORIC)

89.66% of ORIC Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ORIC Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/16/2022	Woodline Partners LP	29,095	$0.16M	0.0%	N/A	0.074%
5/16/2022	State Street Corp	593,549	$3.17M	0.0%	-53.3%	1.503%
5/16/2022	Graham Capital Management L.P.	73,919	$0.39M	0.0%	N/A	0.187%
5/13/2022	Renaissance Technologies LLC	219,100	$1.17M	0.0%	+733.1%	0.555%
5/13/2022	Northern Trust Corp	298,858	$1.60M	0.0%	-4.8%	0.757%
5/13/2022	Charles Schwab Investment Management Inc.	215,513	$1.15M	0.0%	-4.0%	0.546%
5/13/2022	Vanguard Group Inc.	1,644,019	$8.78M	0.0%	+0.9%	4.164%
5/12/2022	BlackRock Inc.	2,373,900	$12.68M	0.0%	-1.7%	6.019%
5/12/2022	Acadian Asset Management LLC	5,507	$29K	0.0%	N/A	0.014%
5/12/2022	Citigroup Inc.	5,942	$32K	0.0%	-90.3%	0.015%
5/11/2022	JPMorgan Chase & Co.	19,654	$0.11M	0.0%	+23.9%	0.050%
5/11/2022	GSA Capital Partners LLP	42,507	$0.23M	0.0%	+77.5%	0.108%
5/9/2022	Swiss National Bank	60,600	$0.32M	0.0%	+7.6%	0.154%
5/6/2022	Los Angeles Capital Management LLC	35,830	$0.19M	0.0%	+75.8%	0.091%
5/4/2022	Victory Capital Management Inc.	47,919	$0.16M	0.0%	-97.3%	0.121%
4/29/2022	Nisa Investment Advisors LLC	16,100	$86K	0.0%	N/A	0.041%
2/23/2022	BlackRock Inc.	2,415,347	$35.50M	0.0%	+0.2%	6.133%
2/19/2022	Wells Fargo & Company MN	182,161	$2.68M	0.0%	-84.9%	0.463%
2/17/2022	Goldman Sachs Group Inc.	43,915	$0.65M	0.0%	+8.6%	0.112%
2/16/2022	Deutsche Bank AG	19,422	$0.29M	0.0%	-11.3%	0.049%
2/16/2022	California State Teachers Retirement System	38,428	$0.57M	0.0%	+5.4%	0.098%
2/16/2022	Parametric Portfolio Associates LLC	63,228	$0.93M	0.0%	+12.6%	0.161%
2/15/2022	Susquehanna International Group LLP	25,982	$0.38M	0.0%	+52.2%	0.066%
2/14/2022	PDT Partners LLC	33,057	$0.49M	0.0%	N/A	0.084%
2/14/2022	Virtus ETF Advisers LLC	13,677	$0.20M	0.1%	+26.9%	0.035%
2/14/2022	Corton Capital Inc.	16,912	$0.25M	0.1%	N/A	0.043%
2/14/2022	Suvretta Capital Management LLC	440,696	$6.48M	0.1%	+195.6%	1.119%
2/14/2022	Alliancebernstein L.P.	33,000	$0.49M	0.0%	+16.6%	0.084%
2/14/2022	Credit Suisse AG	18,391	$0.27M	0.0%	+13.8%	0.047%
2/14/2022	State Street Corp	1,271,828	$18.70M	0.0%	+20.0%	3.229%
2/14/2022	Goldman Sachs Group Inc.	43,915	$0.65M	0.0%	+8.6%	0.112%
2/14/2022	Nuveen Asset Management LLC	111,159	$1.31M	0.0%	-6.8%	0.282%
2/14/2022	GSA Capital Partners LLP	23,954	$0.35M	0.0%	N/A	0.061%
2/14/2022	Invesco Ltd.	12,010	$0.18M	0.0%	-11.2%	0.030%
2/11/2022	Geode Capital Management LLC	615,872	$9.05M	0.0%	-5.4%	1.564%
2/11/2022	Renaissance Technologies LLC	26,300	$0.39M	0.0%	N/A	0.067%
2/11/2022	Charles Schwab Investment Management Inc.	224,431	$3.30M	0.0%	+2.2%	0.570%
2/11/2022	Ensign Peak Advisors Inc	10,360	$0.15M	0.0%	N/A	0.026%
2/11/2022	Column Group LLC	3,568,181	$52.45M	7.1%	-25.2%	9.060%
2/10/2022	JPMorgan Chase & Co.	15,860	$0.23M	0.0%	-27.7%	0.040%
2/10/2022	Rafferty Asset Management LLC	68,423	$1.01M	0.0%	+118.5%	0.174%
2/10/2022	Citigroup Inc.	61,233	$0.90M	0.0%	+130.6%	0.155%
2/8/2022	Jennison Associates LLC	985,072	$14.48M	0.0%	-1.5%	2.501%
2/8/2022	Bank of America Corp DE	77,863	$1.15M	0.0%	+500.1%	0.198%
2/8/2022	Swiss National Bank	56,300	$0.83M	0.0%	+7.0%	0.143%
2/8/2022	Northern Trust Corp	313,783	$4.61M	0.0%	-1.0%	0.797%
2/7/2022	Victory Capital Management Inc.	1,805,717	$26.54M	0.0%	+16.8%	4.585%
2/7/2022	SG Americas Securities LLC	13,650	$0.20M	0.0%	-45.9%	0.035%
2/7/2022	M&T Bank Corp	20,536	$0.30M	0.0%	+40.3%	0.052%
2/4/2022	Beacon Investment Advisory Services Inc.	15,000	$0.22M	0.0%	-14.6%	0.038%
2/2/2022	New York State Common Retirement Fund	19,557	$0.29M	0.0%	-17.5%	0.050%
1/28/2022	Allspring Global Investments Holdings LLC	1,000,199	$14.70M	0.0%	N/A	2.540%
1/24/2022	Regents of The University of California	148,322	$2.18M	0.3%	N/A	0.377%
11/22/2021	EcoR1 Capital LLC	3,468,944	$72.54M	2.5%	+12.2%	8.808%
11/19/2021	American International Group Inc.	17,305	$0.36M	0.0%	+4.7%	0.044%
11/18/2021	Bank of New York Mellon Corp	110,814	$2.32M	0.0%	+35.4%	0.281%
11/17/2021	ArrowMark Colorado Holdings LLC	1,249,707	$26.13M	0.2%	+22.3%	3.173%
11/16/2021	Suvretta Capital Management LLC	149,100	$3.12M	0.1%	N/A	0.379%
11/16/2021	UBS Group AG	25,986	$0.54M	0.0%	+259.0%	0.066%
11/16/2021	Laurion Capital Management LP	47,821	$1M	0.0%	-21.6%	0.121%
11/16/2021	Metropolitan Life Insurance Co NY	8,546	$0.18M	0.0%	+17.2%	0.022%
11/16/2021	Citadel Advisors LLC	15,377	$0.32M	0.0%	-20.4%	0.039%
11/15/2021	Point72 Asset Management L.P.	333,782	$6.98M	0.0%	-64.6%	0.848%
11/15/2021	Cubist Systematic Strategies LLC	2,145	$45K	0.0%	-80.5%	0.005%
11/15/2021	California State Teachers Retirement System	36,443	$0.76M	0.0%	-10.4%	0.093%
11/15/2021	Royal Bank of Canada	3,370	$70K	0.0%	+66.8%	0.009%
11/15/2021	Morgan Stanley	18,914	$0.40M	0.0%	-87.0%	0.048%
11/15/2021	Invesco Ltd.	13,526	$0.28M	0.0%	+14.8%	0.034%
11/15/2021	Virtus ETF Advisers LLC	10,782	$0.23M	0.1%	-5.0%	0.027%
11/15/2021	Voya Investment Management LLC	183,512	$3.84M	0.0%	+19.9%	0.466%
11/12/2021	The Manufacturers Life Insurance Company	16,163	$0.34M	0.0%	-5.0%	0.041%
11/12/2021	Credit Suisse AG	16,167	$0.34M	0.0%	+23.3%	0.041%
11/12/2021	Geode Capital Management LLC	651,224	$13.62M	0.0%	+59.7%	1.656%
11/10/2021	US Bancorp DE	1,355	$28K	0.0%	N/A	0.003%
11/10/2021	Goldman Sachs Group Inc.	40,421	$0.85M	0.0%	+19.9%	0.103%
11/10/2021	Citigroup Inc.	26,553	$0.56M	0.0%	-68.5%	0.068%
11/10/2021	Rafferty Asset Management LLC	31,311	$0.66M	0.0%	-34.3%	0.080%
11/9/2021	BlackRock Inc.	2,410,542	$50.41M	0.0%	+6.2%	6.131%
11/9/2021	Jennison Associates LLC	999,876	$20.91M	0.0%	+0.3%	2.543%
11/8/2021	Los Angeles Capital Management LLC	20,380	$0.43M	0.0%	-6.9%	0.052%
11/4/2021	Deutsche Bank AG	21,904	$0.46M	0.0%	+8.4%	0.056%
11/2/2021	New York State Common Retirement Fund	23,702	$0.50M	0.0%	-13.1%	0.060%
11/2/2021	Victory Capital Management Inc.	1,546,323	$32.33M	0.0%	+18.6%	3.933%
11/1/2021	SG Americas Securities LLC	25,235	$0.53M	0.0%	N/A	0.064%
10/28/2021	M&T Bank Corp	14,635	$0.31M	0.0%	N/A	0.037%
10/28/2021	Emerald Mutual Fund Advisers Trust	742,666	$15.53M	0.5%	+33.3%	1.889%
10/28/2021	Emerald Advisers LLC	726,236	$15.19M	0.6%	+20.5%	1.847%
10/19/2021	JJJ Advisors Inc.	9,118	$84K	0.0%	N/A	0.023%
9/3/2021	Parametric Portfolio Associates LLC	35,581	$0.63M	0.0%	-6.1%	0.090%
8/23/2021	Morgan Stanley	146,015	$2.58M	0.0%	+1,033.2%	0.371%
8/17/2021	Wells Fargo & Company MN	1,241,281	$21.96M	0.0%	+3.1%	3.157%
8/17/2021	Invesco Ltd.	11,778	$0.21M	0.0%	N/A	0.030%
8/17/2021	Metropolitan Life Insurance Co NY	7,292	$0.13M	0.0%	+104,071.4%	0.019%
8/17/2021	Millennium Management LLC	231,853	$4.10M	0.0%	+87.8%	0.590%
8/17/2021	ArrowMark Colorado Holdings LLC	1,021,898	$18.08M	0.1%	-0.5%	2.599%
8/17/2021	Citadel Advisors LLC	19,315	$0.34M	0.0%	N/A	0.049%
8/16/2021	Bank of America Corp DE	19,814	$0.35M	0.0%	+92.4%	0.050%
8/16/2021	UBS Asset Management Americas Inc.	13,033	$0.23M	0.0%	+18.5%	0.033%
8/16/2021	Point72 Asset Management L.P.	944,001	$16.70M	0.1%	-26.6%	2.401%
8/16/2021	Cubist Systematic Strategies LLC	11,024	$0.20M	0.0%	+716.6%	0.028%

Data available starting January 2016

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers. The company's product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. It has collaboration and license agreement with Voronoi, Inc.; and Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

Today's Range

Now: $3.53

$3.02

$3.53

50 Day Range

MA: $4.86

$2.70

$7.60

52 Week Range

Now: $3.53

$2.62

$26.70

Volume

32,671 shs

Average Volume

511,284 shs

Market Capitalization

$139.36 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.4

Who are the company insiders with the largest holdings of ORIC Pharmaceuticals?: ORIC Pharmaceuticals' top insider shareholders include:
Jacob Chacko (CEO)
Richard H Scheller (Director)
Richard A Heyman (Director)
Richard A Heyman (Director)
Carl L Gordon (Director)
Dominic Piscitelli (CFO)
Orbimed Advisors Llc (Director)
Learn More about top insider investors at ORIC Pharmaceuticals.
Who are the major institutional investors of ORIC Pharmaceuticals?: ORIC Pharmaceuticals' top institutional investors include:
BlackRock Inc. — 6.02%
Vanguard Group Inc. — 4.16%
State Street Corp — 1.50%
Northern Trust Corp — 0.76%
Renaissance Technologies LLC — 0.55%
Charles Schwab Investment Management Inc. — 0.55%
Learn More about top institutional investors of ORIC Pharmaceuticals stock.
Which institutional investors are selling ORIC Pharmaceuticals stock?: During the last quarter, ORIC stock was sold by these institutional investors:
Victory Capital Management Inc.
State Street Corp
Citigroup Inc.
BlackRock Inc.
Northern Trust Corp
Charles Schwab Investment Management Inc.
In the previous year, company insiders that have sold ORIC Pharmaceuticals company stock include:
Jacob Chacko (CEO)
Richard H Scheller (Director)
Learn More investors selling ORIC Pharmaceuticals stock.
Which institutional investors are buying ORIC Pharmaceuticals stock?: During the previous quarter, ORIC stock was bought by institutional investors including:
Renaissance Technologies LLC
Graham Capital Management L.P.
Woodline Partners LP
GSA Capital Partners LLP
Nisa Investment Advisors LLC
Los Angeles Capital Management LLC
Vanguard Group Inc.
Acadian Asset Management LLC
During the previous year, these company insiders have bought ORIC Pharmaceuticals stock:
Jacob Chacko (CEO)
Richard H Scheller (Director)
Learn More investors buying ORIC Pharmaceuticals stock.

The Last Great Value Stock